ARADyAL: The Spanish Multidisciplinary Research Network for Allergic Diseases
M J Torres 1 2 3 4 , J Agundez 5 , D Barber 6 , J Bartra 7 8 , I Davila 9 , M M Escribese 10 , M Fernandez-Rivas 11 , M Ferrer 12 , E Perez-Inestrosa 3 13 , M Villalba 14 , C Mayorga 1 2 3
Thematic cooperative health research networks (RETICS) are organizational structures promoted by the Instituto de Salud Carlos III of the Spanish Ministry of Science with the objective of carrying out cooperative research projects addressing challenges of general interest for society as a whole in the field of health care.
The RETICS of Asthma, Adverse Drug Reactions, and Allergy (ARADyAL) received funding in 2016 for a 5-year program (2017-2021). ARADyAL integrates basic and clinical research in the areas of allergy, immunology, genetics, nanomedicine, pharmacology, and chemistry, with special interest in research on new biomarkers and the design and evaluation of new interventions for allergic patients with severe phenotypes.
The consortium comprises 28 groups across Spain, including 171 clinical and basic researchers, 17 clinical groups that cover more than 10 000 000 patients of all ages from urban and rural areas and 11 basic groups active mostly at universities and research institutes. ARADyAL has proposed a research program organized into 3 different areas focusing on precision medicine, as follows: Program 1, Mechanisms and prediction of adverse drug reactions and allergic diseases; Program 2, Toward a precise diagnosis of allergic diseases; and Program 3, Predicting interventions in allergic diseases.
There is also 1 common program dedicated to training. The network has a Steering Committee and an External Advisory Scientific Committee, which advise the global network coordinator, who has recognized expertise in the field. ARADyAL is a unique meeting point for clinicians and basic scientists who are already working in allergy.
CITATION J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):108-119. doi: 10.18176/jiaci.0629. Epub 2020 Jul 22.